Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.
Neuroleptic malignant syndrome is a rare complication when using neuroleptic drugs. We report the case of a patient with severe Parkinson's disease who developed neuroleptic malignant syndrome after withdrawal of his antiParkinsonian medication for elective coronary artery bypass grafting. Sodium dantrolene may be a therapeutic option in severe cases.
Stotz
M
M
Department of Anaesthesia, University of Basel/Kantonsspital, CH-4031 Basel, Switzerland. Stotzm@hotmail.com
Thümmler
D
D
Schürch
M
M
Renggli
J-C
JC
Urwyler
A
A
Pargger
H
H
D000978:Antiparkinson Agents / Q000009:adverse effects*; D001026:Coronary Artery Bypass; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D011183:Postoperative Complications / Q000175:diagnosis*; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis*
D000978:Antiparkinson Agents